What caused ALAIR.PA stock to fall pre-market on 24 Feb 2026?

The pre-market decline to **€0.71** (-8.46%) reflects thin liquidity, negative EPS **-€0.46**, rising volume and concerns over working capital. Sector performance is positive while company-specific cash-flow weakness and higher leverage drove selling.

What is Meyka AI's short-term forecast for ALAIR.PA stock?

Meyka AI's model projects a monthly price of **€0.45** (implied downside **-36.98%**) and a quarterly target of **€1.13** (implied upside **+58.26%**). These are model projections, not guarantees.

Is ALAIR.PA stock a buy, hold or sell based on current data?

Meyka AI assigns ALAIR.PA a score of **62.08** (Grade **B**, Suggestion: **HOLD**). The recommendation reflects mixed valuation and operational risk; investors should wait for clearer cash-flow improvement or better liquidity.

Which metrics should investors watch for ALAIR.PA stock?

Focus on earnings updates, operating cash flow, days sales outstanding (**111.97**), inventory cycles and trading volume. Improvements in free cash flow and interest coverage would materially reduce downside risk.

EU Stocks

Pre-market: ALAIR.PA Mexedia down 8.46% to €0.71 on 24 Feb 2026: Liquidity risk

ByHuzaifa Zahoor February 24, 2026

ALAIR.PA stock is the top pre-market loser on EURONEXT on 24 Feb 2026 after shares fell 8.46% to €0.71. The drop follows weak trading where volume rose to 15,924 shares versus an average of 11,596, and continues a YTD decline of 42.28%. Investors we spoke with flag thin liquidity, negative EPS and stretched working capital as immediate triggers. This report breaks down price drivers, valuation, technical signals and Meyka AI forecasts to show where risk and opportunity sit in the short term.